Twist Bioscience Corp 2025 SR
The report highlights Twist Bioscience's commitment to sustainability through its proprietary silicon-based DNA synthesis platform, which uses 99.8% less chemicals than traditional methods. In fiscal 2024, the company achieved record revenue of $313 million and committed to setting science-based emissions targets through the SBTi. Key environmental achievements include significant reductions in the carbon footprint of gene and oligo manufacturing and the diversion of over 31,000 pounds of nitrile gloves from landfills. The company also emphasizes its diverse workforce, with women making up 44% of the total staff and 55% of the U.S. workforce identifying as people of color.
Company: Twist Bioscience Corp
Sector: Health Care
Country: United States
Year: 2025
Type: SR
Pages: 59
Twist Bioscience Corp
Corporate Responsibility Report
The report highlights Twist Bioscience's commitment to sustainability through its proprietary silicon-based DNA synthesis platform, which uses 99.8% less chemicals than traditional methods. In fiscal 2024, the company achieved record revenue of $313 million and committed to setting science-based emissions targets through the SBTi. Key environmental achievements include significant reductions in the carbon footprint of gene and oligo manufacturing and the diversion of over 31,000 pounds of nitrile gloves from landfills. The company also emphasizes its diverse workforce, with women making up 44% of the total staff and 55% of the U.S. workforce identifying as people of color.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Oct 1, 2023 - Sep 30, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Women in Management